CDEK
← All drugs Report issue

bifidobacterium bifidum

Cell therapyexperimental

Clinical trial activity

52 trials · 64 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
7
Phase 3
5
Phase 4
1

Earliest trial started Oct 1, 2004 (NCT00282113)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • b. bifidum
  • bifidobacterium bifidum
  • bifidobacterium bifidum g9-1
  • bifidobacterium bifidum malyoth
  • bifidobacterium bifidum r0071
  • bifidobacterium bifidum w23
  • bifidobacterium bifidus
  • probiotic

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07165457N/ASep 4, 2025Clinica Universidad de Navarra
NCT07081100N/AAug 5, 2025Wecare Probiotics Co., Ltd.
NCT06873438N/AMar 10, 2025Wecare Probiotics Co., Ltd.
NCT06470906N/AAug 14, 2024Columbia University
NCT06899620N/AJul 1, 2024Wecare Probiotics Co., Ltd.
NCT06629441N/AJun 20, 2024Wecare Probiotics Co., Ltd.
NCT06607562N/AJun 3, 2024Wecare Probiotics Co., Ltd.
NCT06719596Phase 1/Phase 2 (Phase 2)May 10, 2024Nanjing University
NCT07072871N/AApr 1, 2024PT Royal Medikalink Pharmalab
NCT05674981N/AApr 24, 2023Chung Shan Medical University, GenMont Biotech Incorporation
NCT05730777Phase 4Feb 15, 2023Peking University
NCT05666115N/AJan 15, 2023Camilo Jose Cela University
NCT05762887N/AJan 9, 2023Baszucki Brain Research Fund, Milken Family Foundation, University of Sao Paulo
NCT05355571N/AMay 31, 2022Comac Medical, Cultech Ltd,
NCT05358743N/AMay 1, 2022Alexandria University
NCT05332626N/AFeb 1, 2022Poznan University
NCT05620004Phase 1/Phase 2 (Phase 2)Nov 1, 2021Sun Yat-Sen University
NCT04854941N/ADec 10, 2020I.M. Sechenov First Moscow State Medical University
NCT04420676N/AAug 31, 2020Medical University of Graz
NCT04374955N/AJul 31, 2020Halic University, Nobel Pharmaceuticals
Showing 20 of 52 trials
Page 1 / 3

Organizations

Research & Development (64)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Wecare Probiotics Co., Ltd.For profit5512024
Lallemand SASFor profit4112008
Medical University of GrazAcademic/Hospital4412015
University of FloridaAcademic/Hospital4412012
China Medical UniversityAcademic/Hospital2212017
Tokyo Women's Medical UniversityAcademic/Hospital2212007
University of CalgaryAcademic/Hospital2222017
Wakunaga Pharmaceutical Co., Ltd.For profit2012015
Winclove Bio Industries BVFor profit2012018
Alexandria UniversityAcademic/Hospital1112022
AXIS Clinicals LimitedFor profit1012012
Baszucki Brain Research FundAcademic/Hospital1012023
BiofortisFor profit1012008
Cairo UniversityAcademic/Hospital1112018
Camilo Jose Cela UniversityAcademic/Hospital1112023
Centro medicina deportiva Miranda EbroAcademic/Hospital1012018
Chung Shan Medical UniversityAcademic/Hospital1012023
Clinical Research Associates of TidewaterFor profit1012012
Clinica Universidad de NavarraAcademic/Hospital1112025
Columbia UniversityAcademic/Hospital1112024
64 organizations
Page 1 / 4